Oxford BioMedica PLC (OXBDF)

[marcusl2]

Good news. Orchard should be quite a valuable company in time. OXB will do well.

Additionally, Oxford BioMedica will receive a low single-digit royalty on net sales of licensed products until January 31, 2039. In the event the products are used for compassionate use, these royalties are reduced by a mid-double-digit percentage. Orchard Therapeutics is also required to pay a set monthly fee to Oxford BioMedica in the event the Group's system for generating stable cell lines is used.


The last line may be a pointer to the earning power of TRiP ?


This is from the CF deal; The collaboration may also include an evaluation of Oxford BioMedica’s Transgene Repression in vector Production (TRiP) System, and the development of stable producer cell lines for large scale production of the lentiviral vector.
HTTps://www.oxfordbiomedica.co.uk/news-media/press-release/oxford-biomedica-uk-cystic-fibrosis-gene-therapy-consortium-boehringer

Oxford BioMedica currently owns 1,111,924 shares in Orchard Therapeutics

https://uk.advfn.com/stock-market/london/oxford-biomedica-OXB/share-news/Oxford-Biomedica-PLC-Details-of-alliance-with-Orch/78403980